Search Results - "Prokopenko, Polina"
-
1
A novel immunofluorescent test system for SARS-CoV-2 detection in infected cells
Published in PloS one (31-05-2024)“…Highly variable pandemic coronavirus SARS-CoV-2, which causes the hazardous COVID-19 infection, has been persistent in the human population since late 2019. A…”
Get full text
Journal Article -
2
Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model
Published in Viruses (13-01-2023)“…COVID-19 cases caused by new variants of highly mutable SARS-CoV-2 continue to be identified worldwide. Effective control of the spread of new variants can be…”
Get full text
Journal Article -
3
Detection of IFNγ-Secreting CD4+ and CD8+ Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2
Published in Viruses (01-08-2021)“…Background: New coronavirus SARS-CoV-2, a causative agent of the COVID-19 pandemic, has been circulating among humans since November 2019. Multiple studies…”
Get full text
Journal Article -
4
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza
Published in Virology journal (09-04-2024)“…Influenza and SARS-CoV-2 are two major respiratory pathogens that cocirculate in humans and cause serious illness with the potential to exacerbate disease in…”
Get full text
Journal Article -
5
Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site
Published in Human vaccines & immunotherapeutics (02-12-2018)“…The development of viral vector vaccines against various pathogens for which conventional vaccination approaches are not applicable has been a priority for a…”
Get full text
Journal Article -
6
Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein
Published in Vaccines (Basel) (21-02-2023)“…Current seasonal influenza vaccines have suboptimal effectiveness, especially in seasons dominated by viruses that do not match the vaccine. Therefore, finding…”
Get full text
Journal Article -
7
Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
Published in Vaccines (Basel) (18-07-2022)“…The COVID-19 pandemic emerged in 2020 and has caused an unprecedented burden to all countries in the world. SARS-CoV-2 continues to circulate and antigenically…”
Get full text
Journal Article -
8
Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates
Published in Vaccines (Basel) (26-09-2024)“…Influenza and SARS-CoV-2 viruses are two highly variable pathogens. We have developed a candidate bivalent live vaccine based on the strain of licensed…”
Get full text
Journal Article -
9
Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections
Published in Vaccines (Basel) (24-04-2020)“…Human adenoviruses (AdVs) are one of the most common causes of acute respiratory viral infections worldwide. Multiple AdV serotypes with low cross-reactivity…”
Get full text
Journal Article -
10
Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses
Published in Antiviral research (01-10-2020)“…Respiratory syncytial virus (RSV) can cause recurrent infection in people because it does not stimulate a long-lived immunological memory. There is an urgent…”
Get full text
Journal Article -
11
Influenza vaccine: progress in a vaccine that elicits a broad immune response
Published in Expert review of vaccines (02-09-2021)“…The licensed seasonal influenza vaccines predominantly induce neutralizing antibodies against immunodominant hypervariable epitopes of viral surface proteins,…”
Get more information
Journal Article -
12
Enhancement of systemic and lung-localized CD4+ T-cell immune responses by truncation of NS1 protein of a seasonal live influenza vaccine strain
Published in Žurnal mikrobiologii, ėpidemiologii i immunobiologii (18-11-2024)“…Introduction. There is a large variety of licensed influenza vaccines worldwide, but their common limitation is rather narrow specificity and inability to…”
Get full text
Journal Article -
13
Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters
Published in Vaccines (Basel) (21-11-2024)“…Background/Objectives: Influenza viruses and SARS-CoV-2 are currently cocirculating with similar seasonality, and both pathogens are characterized by a high…”
Get full text
Journal Article -
14
Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site
Published in Human Vaccines & Immunotherapeutics (02-12-2018)“…The development of viral vector vaccines against various pathogens for which conventional vaccination approaches are not applicable has been a priority for a…”
Get full text
Report